Tag: OCD

Entropy Neurodynamics Wins Ethics Approval for World-First Eight-Indication Psilocin Trial

by Psychedelics.Media Team

August 6, 2026

Australian psychedelic biotechnology company Entropy Neurodynamics (ASX: ENP) has secured Human Research Ethics Committee (HREC) approval to begin what it ...

No Result

View All Result

Home
News
Business
Policy & Regulation
Research
Health & Therapy
Opinion
Contact

Not enough quota to unlock this post

Unlock left : 0

Tag: OCD

Entropy Neurodynamics Wins Ethics Approval for World-First Eight-Indication Psilocin Trial

Newsletter

Stay Ahead of Psychedelic Medicine

Recommended

María Sabina: The Woman at the Heart of the Psychedelic Story

ASX Cannabis Sector FY26 Results: From Cannabis to Regulated Therapeutics

Popular Story

Incannex and the Next Test for Psychedelic Medicine

BLS Pharmaceuticals expands commercial leadership with new Strategic Partnership Director

The Global Psychedelic Medicine Conference & Events Calendar 2026–2027

Eli Lilly Reportedly Nears Acquisition of AtaiBeckley in Potential Landmark Deal for Psychedelic Medicine

AbbVie’s $906M Psychedelic Bet: What It Means for Psychedelic Medicine

Recent Posts

Categories

Free Weekly Newsletter

Not enough quota to unlock this post

Are you sure want to cancel subscription?